GABRIELA SELF: Open Payments
NPI 1801556550 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 5 payments from 4 companies in 2025. Trend: 2023 $1,081 · 2024 $1,765 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $240 |
| Alkermes, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
Products named: Auvelity, VIVITROL, ABILIFY MAINTENA, INGREZZA.
Industry payments across CT — which companies pay providers there.
